Opinion · 22 Oct 2024
ArticlePublished 2011
ENHANCEMENT OF SOLUBILITY AND DISSOLUTION PROPERTY OF GRISEOFULVIN BY NANOCRYSTALLIZATION
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The aim of this study was to develop the formulation of griseofulvin by nanocrystallization for the enhancement of solubility and dissolution property of drug. In the present study the area of interest are drugs belonging to class II of BCS classification. Nanocrystal is a new carrier free colloidal drug delivery system with particle size ranging from 100-1000 nm, and is considered as a viable drug delivery strategy to develop the poorly soluble drugs. In the present work an attempt was made to enhance bioavailability of Griseofulvin by nanocrystallization technique. The drug nanocrystals (NC) were prepared by emulsion solvent diffusion method. Two different solvents such as acetone and ethanol and two different stabilizers such as β-cyclodextrin and sodium lauryl sulphite (SLS) were evaluated in the process. All formulations were in the size range of 600-900nm and showed marked improvement in dissolution velocity when compared to pure drug (3-4 μm), thus greater bioavailability. Short term stability studies were carried out as per ICH guidelines and from the stability studies it was conformed that nanocrystal formulation of griseofulvin remain stable at ambient temperature then at elevated temperature and humidity condition. The diffractograms confirms that the method for preparing nanocrystals does not interfere with griseofulvin state as diffraction patterns are conserved for the formulated nanocrystal formulations. Finally it was concluded that formulating poorly water soluble drugs in the form of drug NC would be a promising approach in delivery of class II drugs by oral route in much efficacious way.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in International Journal of Drug Development and Research.
Opinion · 22 Oct 2024
From Monoclonal Antibodies to CAR-T Therapy: Trends and Transformations in Cancer Treatment
Perspective · 21 Oct 2024
Natural Products in Drug Discovery: From Traditional Remedies to Modern Medicines
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternational Journal of Drug Development and Research
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Phanchaxari M Dandagi”
- BylineArticles whose byline prints “Sumit Kaushik”
- BylineArticles whose byline prints “Shaktish Telsang”
